Company / AR per Share
Ernexa Therapeutics Inc. AR per Share History
FY2014-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.04
FY2020
5-year range
$0.04 / $0.42
FY2016-FY2020
Trend
-90.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2017 to $0.50 in FY2016.
Based on SEC 10-K filings.
0.04 in FY2020 with a 5-year CAGR of +32.1%.
Declined from $0.45 to $0.04 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +73.0%
- 5-Year CAGR
- +32.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, ar per share decreased 90.4% year-over-year.
- Peak ar per share was recorded in FY2016.
- Lowest ar per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2020 | $0.04 | -90.4% |
| FY2019 | $0.42 | -8.3% |
| FY2018 | $0.45 | +5769.9% |
| FY2017 | $0.01 | -98.5% |
| FY2016 | $0.50 | +4944.6% |
| FY2015 | $0.01 | -64.3% |
| FY2014 | $0.03 | +209.0% |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026